|
|
|
Market Cap (in crs)
3,174.24
Face Value
10
Turnover (in lacs)
992.53
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
137.99 Cr | 114.21 Cr | 103.02 Cr | 180.21 Cr | 0.8 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
417.51 Cr | 217.34 Cr | 39.02 Cr | 14.63 Cr |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
21.18 Cr | 17.97 Cr | 16.43 Cr | 23.83 Cr | 0.11 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
58.34 Cr | 32.71 Cr | 8.43 Cr | 0.99 Cr |
Senores Pharmaceuticals Ltd reported a 35.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1FY26). On a year-on-year (YoY) basis, it witnessed a growth of 17350.6%.
Its expenses for the quarter were down by 40.3% QoQ and up 16791.2% YoY.
The net profit decreased 35.2% QoQ and increased 19154.5% YoY.
The earnings per share (EPS) of Senores Pharmaceuticals Ltd stood at 4.6 during Q1FY26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 82821 Rs | 151740 Rs |
Week Rs | 100170 Rs | 205848 Rs |
Month Rs | 131209 Rs | 290899 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
354.00 | 3,549.82 | 298.8 | 504.25 | 363.50 | -2.69% | -2.71% | 5.12% | -11.31% | 52.65% | 0.03% | 58.02 | 41.16 | 5.90 | |
269.80 | 3,326.65 | 245 | 464.75 | 267.95 | 3.81% | 4.92% | -32.85% | -29.09% | -24.71% | 0.30% | 52.78 | 41.16 | 2.63 | |
299.80 | 2,765.59 | 190 | 383 | 304.70 | -2.85% | 2.18% | 29.75% | -18.99% | -16.02% | 0.07% | 0.00 | 41.16 | 2.51 | |
116.04 | 3,406.09 | 57.5 | 122.61 | 115.13 | 4.64% | 23.32% | 88.84% | 15.53% | 54.33% | 0.69% | 32.36 | 41.16 | 2.02 | |
53.76 | 2,945.80 | 42 | 94.45 | 53.33 | -0.70% | 12.23% | 11.14% | -38.04% | 62.42% | 0.37% | 39.53 | 41.16 | 2.49 | |
679.05 | 3,020.80 | 442.8 | 882.8 | 675.45 | 0.73% | 12.08% | 40.36% | -8.59% | 71.93% | 0.00% | 112.78 | 41.16 | 2.25 |
Senores Pharmaceuticals share price is ₹689.25 in NSE and ₹689.1 in BSE as on 17/9/2025.
Senores Pharmaceuticals share price in the past 1-year return was 0. The Senores Pharmaceuticals share hit a 1-year low of Rs. 435.25 and a 1-year high of Rs. 751.2.
The market cap of Senores Pharmaceuticals is Rs. 3174.24 Cr. as of 17/9/2025.
The PE ratios of Senores Pharmaceuticals is 0 as of 17/9/2025.
The PB ratios of Senores Pharmaceuticals is 4.48 as of 17/9/2025
The Mutual Fund Shareholding in Senores Pharmaceuticals was 3% at the end of 17/9/2025.
You can easily buy Senores Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Senores Pharmaceuticals share price is ₹751.2 and ₹435.25 as of 17/9/2025.
The earnings per share (EPS) of Senores Pharmaceuticals stood at 4.6 during Q1FY26.
Please be aware that Senores Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.